<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03190668</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201701129</org_study_id>
    <nct_id>NCT03190668</nct_id>
  </id_info>
  <brief_title>Skeletal Muscle and Adipose Tissue Study</brief_title>
  <official_title>Skeletal Muscle and Adipose Tissue Concentrations of Cefazolin Comparing Two Different Dosing Regimens During Pediatric Posterior Spinal Fusion Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to compare the current standard of care for
      prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of
      Cefazolin during pediatric spinal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determine the skeletal muscle and adipose tissue disposition of prophylactic Cefazolin using
      microdialysis sampling in a cohort of patients diagnosed with idiopathic scoliosis undergoing
      posterior spinal fusion (PSF) for administration of Cefazolin by either continuous infusion
      or intermittent bolus.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Simple randomization will be used with each patient has probability 0.5 to be assigned in Group I or Group II. Computer program will generate a uniform random variable between 0 to 1, with subject assigned to Group I if the value is less than 0.5 and assigned to Group II if the value is greater than 0.5.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle disposition of prophylactic Cefazolin</measure>
    <time_frame>Changes from baseline (pre-op) up to end of surgical procedure</time_frame>
    <description>First regimen and second regimen difference between unbound Cefazolin concentrations in the interstitial fluid of skeletal muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adipose tissue disposition of prophylactic Cefazolin</measure>
    <time_frame>Changes from baseline (pre-op) up to end of surgical procedure</time_frame>
    <description>First regimen and second regimen difference between unbound Cefazolin concentrations in the interstitial fluid of adipose tissue</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Idiopathic Scoliosis</condition>
  <arm_group>
    <arm_group_label>First Regimen Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The first regimen will consist of a bolus dose of Cefazolin 30mg/kg up to a maximum of 2000mg IV administered prior to surgical incision. The same pre-operative dose of Cefazolin will be repeated every 3 hours until the completion of surgery. Two will paraspinal muscle microdialysis catheters and two subcutaneous microdialysis catheters will be inserted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second Regimen Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The second regimen will consist of an initial bolus dose of 30 mg/kg up to maximum of 2000 mg. Following the initial bolus dose a continuous Cefazolin drip will start until the end of surgery. Cefazolin drip dose will be 10 mg/(kg*h) up to maximum of 667 mg/h.Two microdialysis catheters will be inserted into a paraspinal muscle and two microdialysis catheters will be inserted subcutaneously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bolus dose of Cefazolin</intervention_name>
    <description>Mode of Cefazolin administration will be a intermittent bolus</description>
    <arm_group_label>First Regimen Group</arm_group_label>
    <other_name>Standard mode of prophylactic cefazolin administration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Continuous Cefazolin drip</intervention_name>
    <description>Mode of Cefazolin administration will be a continuous drip</description>
    <arm_group_label>Second Regimen Group</arm_group_label>
    <other_name>Continuous infusion of prophylactic cefazolin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Paraspinal muscle microdialysis catheters</intervention_name>
    <description>Two dialysis probes will be inserted into a paraspinal muscle</description>
    <arm_group_label>First Regimen Group</arm_group_label>
    <arm_group_label>Second Regimen Group</arm_group_label>
    <other_name>Paraspinal muscle dialysate sample</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Subcutaneous microdialysis catheters</intervention_name>
    <description>Two dialysis probes will be inserted into a paraspinal subcutaneous region</description>
    <arm_group_label>First Regimen Group</arm_group_label>
    <arm_group_label>Second Regimen Group</arm_group_label>
    <other_name>Subcutaneous dialysate sample</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of idiopathic scoliosis

          -  Planned posterior spinal fusion surgery (PSFS)

          -  Age: 12-20 years old

          -  American Society of Anesthesiology status I or II undergoing posterior spinal fusion
             for at least 6 levels

          -  No known allergy to cefazolin

        Exclusion Criteria:

          -  Known allergy to cefazolin

          -  Anatomical or other abnormalities that precluded insertion of a microdialysis catheter
             into the selected paraspinal muscle

          -  Known renal or hepatic insufficiency or failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taran Sangari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judith M. Wishin, BSN</last_name>
    <phone>352-273-9096</phone>
    <email>jwishin@anest.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Woods, RN</last_name>
    <phone>352-294-8345</phone>
    <email>awoods@anest.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2017</study_first_submitted>
  <study_first_submitted_qc>June 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tissue microdialysis</keyword>
  <keyword>spinal fusion</keyword>
  <keyword>surgical site infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dialysis Solutions</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

